These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 20980916)
1. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression. Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916 [TBL] [Abstract][Full Text] [Related]
2. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1. Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331 [TBL] [Abstract][Full Text] [Related]
3. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats. Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582 [TBL] [Abstract][Full Text] [Related]
4. Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats. Martín-Fernández B; Rubio-Navarro A; Cortegano I; Ballesteros S; Alía M; Cannata-Ortiz P; Olivares-Álvaro E; Egido J; de Andrés B; Gaspar ML; de Las Heras N; Lahera V; Moreno JA PLoS One; 2016; 11(1):e0145946. PubMed ID: 26730742 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of proanthocyanidins in the cardiac alterations induced by aldosterone in rat heart through mineralocorticoid receptor blockade. Martín-Fernández B; de las Heras N; Valero-Muñoz M; Ballesteros S; Yao YZ; Stanton PG; Fuller PJ; Lahera V PLoS One; 2014; 9(10):e111104. PubMed ID: 25353961 [TBL] [Abstract][Full Text] [Related]
6. Relevance of SGK1 in structural, functional and molecular alterations produced by aldosterone in heart. Martín-Fernández B; Valero Muñoz M; de las Heras N; Ballesteros S; Lahera V Horm Mol Biol Clin Investig; 2014 May; 18(2):53-61. PubMed ID: 25390002 [TBL] [Abstract][Full Text] [Related]
7. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension. Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858 [TBL] [Abstract][Full Text] [Related]
8. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354 [TBL] [Abstract][Full Text] [Related]
9. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755 [TBL] [Abstract][Full Text] [Related]
11. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212 [TBL] [Abstract][Full Text] [Related]
12. The Impact of Spironolactone on Markers of Myocardial Oxidative Status, Inflammation and Remodeling in Hyperthyroid Rats. Mayyas FA; Aljohmani AI; Alzoubi KH Curr Mol Pharmacol; 2020; 13(3):206-215. PubMed ID: 31729306 [TBL] [Abstract][Full Text] [Related]
13. SGK1-dependent cardiac CTGF formation and fibrosis following DOCA treatment. Vallon V; Wyatt AW; Klingel K; Huang DY; Hussain A; Berchtold S; Friedrich B; Grahammer F; Belaiba RS; Görlach A; Wulff P; Daut J; Dalton ND; Ross J; Flögel U; Schrader J; Osswald H; Kandolf R; Kuhl D; Lang F J Mol Med (Berl); 2006 May; 84(5):396-404. PubMed ID: 16604333 [TBL] [Abstract][Full Text] [Related]
14. Aldosterone-induced inflammation in the rat heart : role of oxidative stress. Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524 [TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans. Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775 [TBL] [Abstract][Full Text] [Related]
16. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice. Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025 [TBL] [Abstract][Full Text] [Related]
17. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434 [TBL] [Abstract][Full Text] [Related]
18. Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats. Kitada K; Nakano D; Liu Y; Fujisawa Y; Hitomi H; Shibayama Y; Shibata H; Nagai Y; Mori H; Masaki T; Kobori H; Nishiyama A PLoS One; 2012; 7(7):e41896. PubMed ID: 22911865 [TBL] [Abstract][Full Text] [Related]
19. Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone. Lal A; Veinot JP; Leenen FH Am J Hypertens; 2003 Apr; 16(4):319-23. PubMed ID: 12670750 [TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats. Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]